Response of Lymphangioleiomyomatosis to a Mammalian Target of Rapamycin Inhibitor (Temsirolimus) –Based Treatment
Year: 2011
Type: article
Source: Journal of Clinical Oncology
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2027203907
